Heartflow, Inc.’s Lock-Up Period Will End on February 4th (NASDAQ:HTFL)

Heartflow’s (NASDAQ:HTFL) lock-up period is set to end on Wednesday, February 4th. Heartflow had issued 16,666,667 shares in its initial public offering on August 8th. The total size of the offering was $316,666,673 based on an initial share price of $19.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Analyst Ratings Changes

A number of research analysts recently commented on the company. JPMorgan Chase & Co. upped their price objective on Heartflow from $36.00 to $40.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Stifel Nicolaus boosted their price target on shares of Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, November 13th. Canaccord Genuity Group increased their price objective on shares of Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a report on Thursday, November 13th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Heartflow in a research note on Monday, December 29th. Four analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $38.60.

Heartflow Price Performance

Shares of HTFL opened at $31.21 on Wednesday. Heartflow has a one year low of $25.38 and a one year high of $41.22. The company’s fifty day simple moving average is $30.59. The firm has a market capitalization of $2.66 billion and a price-to-earnings ratio of -17.24.

Insider Buying and Selling

In related news, Director Jeffrey C. Lightcap purchased 40,000 shares of the company’s stock in a transaction on Tuesday, December 16th. The shares were bought at an average cost of $26.34 per share, for a total transaction of $1,053,600.00. Following the transaction, the director owned 40,000 shares of the company’s stock, valued at $1,053,600. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link.

Hedge Funds Weigh In On Heartflow

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wellington Management Group LLP bought a new stake in shares of Heartflow in the 3rd quarter worth $164,263,000. Baillie Gifford & Co. acquired a new position in Heartflow during the third quarter worth about $101,182,000. Schusterman Interests LLC acquired a new position in Heartflow during the third quarter worth about $65,274,000. Vanguard Group Inc. acquired a new stake in Heartflow in the 3rd quarter valued at about $48,871,000. Finally, Capital International Investors bought a new position in shares of Heartflow during the 3rd quarter valued at about $43,671,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.